Digital twin-guided virtual drug test predicts post-ablation recurrence via rotor suppression in atrial fibrillation

12 April 2026 (08:30 - 09:15)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Taehyun Hwang

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail

Atrial posterior wall fibrosis >25% signals atrial fibrillation recurrence

Doctor Y. Zhang (Shenyang, CN)

Abstract Slides Video

Presentation thumbnail

Identification of clinical risk factors for arrhythmia recurrence in atrail fibrillation patients undergoing catheter ablation: a systematic review and meta-analysis

Ms K. Chan (Hong Kong, HK)

Abstract Slides Video

Presentation thumbnail

Strategic factors to reduce recurrence after trido catheter ablation for atrial fibrillation

Doctor Y. Choi (Seoul, KR)

Abstract Slides

Presentation thumbnail

Incidence and predictors of atrial fibrillation recurrence after percutaneous ablation in the elderly population: insights from a single-center registry

Doctor H. Hussein (Coventry, GB)

Abstract Slides Video

Presentation thumbnail

Defining the limits of pulmonary vein isolation: electroanatomic substrate predicts recurrence in first-time paroxysmal atrial fibrillation ablation

Doctor T. Baykaner (Stanford, US)

Abstract Slides Video

Access the full session

Session thumbnail

Arrhythmia recurrences post atrial fibrillation ablation

The Event

Event poster

EHRA 2026

12 April 2026 08:30 CET

You may be interested in

Congress Presentation

CUVIA: digital twin-guided rotor ablation for persistent atrial fibrillation

Congress Presentation

Digital twins for precision rhythmology: ready for prime time?

Congress Presentation

Standard ablation strategies for atrial fibrillation in a heart model

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources